{"id":"https://openalex.org/W2185472884","doi":null,"title":"Passive immunotherapy - a viable treatment for Alzheimer's disease.","display_name":"Passive immunotherapy - a viable treatment for Alzheimer's disease.","publication_year":2014,"publication_date":"2014-11-01","ids":{"openalex":"https://openalex.org/W2185472884","mag":"2185472884","pmid":"https://pubmed.ncbi.nlm.nih.gov/25413550"},"language":"en","primary_location":{"id":"pmid:25413550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25413550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073256304","display_name":"Keonwoo Yi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Keonwoo Yi","raw_affiliation_strings":["Downing College Cambridge, School of Clinical Medicine, University of Cambridge, Cambridge, UK, ky253@cam.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Downing College Cambridge, School of Clinical Medicine, University of Cambridge, Cambridge, UK, ky253@cam.ac.uk","institution_ids":["https://openalex.org/I241749"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073256304"],"corresponding_institution_ids":["https://openalex.org/I241749"],"apc_list":null,"apc_paid":null,"fwci":0.1223,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.40727028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26 Suppl 1","issue":null,"first_page":"256","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/passive-immunotherapy","display_name":"passive immunotherapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.9399999976158142},{"id":"https://openalex.org/keywords/meningoencephalitis","display_name":"meningoencephalitis","score":0.800000011920929},{"id":"https://openalex.org/keywords/vasogenic-edema","display_name":"vasogenic edema","score":0.8330000042915344},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7760000228881836},{"id":"https://openalex.org/keywords/polyclonal-antibodies","display_name":"polyclonal antibodies","score":0.7649999856948853},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7016054391860962},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6062906384468079},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5811396837234497},{"id":"https://openalex.org/C2778621254","wikidata":"https://www.wikidata.org/wiki/Q2346415","display_name":"Meningoencephalitis","level":2,"score":0.46323415637016296},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4400375485420227},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2130599021911621},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1473211944103241}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:25413550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25413550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria Danubina","raw_type":"Journal Article"},{"id":"mag:2185472884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25413550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W195118146","https://openalex.org/W1567490604","https://openalex.org/W1608225731","https://openalex.org/W1671426288","https://openalex.org/W1967549235","https://openalex.org/W1978266853","https://openalex.org/W1979993283","https://openalex.org/W1991993391","https://openalex.org/W1996660046","https://openalex.org/W1998076790","https://openalex.org/W1999945465","https://openalex.org/W2000917982","https://openalex.org/W2001436176","https://openalex.org/W2009174342","https://openalex.org/W2013078308","https://openalex.org/W2015389516","https://openalex.org/W2024077985","https://openalex.org/W2031179697","https://openalex.org/W2035000249","https://openalex.org/W2039550162","https://openalex.org/W2041425500","https://openalex.org/W2046847750","https://openalex.org/W2047427096","https://openalex.org/W2049354825","https://openalex.org/W2054095349","https://openalex.org/W2054619408","https://openalex.org/W2056470407","https://openalex.org/W2058614488","https://openalex.org/W2071982060","https://openalex.org/W2076299101","https://openalex.org/W2078670226","https://openalex.org/W2086354676","https://openalex.org/W2086572083","https://openalex.org/W2095211108","https://openalex.org/W2096576951","https://openalex.org/W2096898082","https://openalex.org/W2099370040","https://openalex.org/W2101276626","https://openalex.org/W2103708669","https://openalex.org/W2122825604","https://openalex.org/W2127914798","https://openalex.org/W2130851089","https://openalex.org/W2143331187","https://openalex.org/W2145073071","https://openalex.org/W2166587617","https://openalex.org/W2166949035","https://openalex.org/W2167818155","https://openalex.org/W2168496031","https://openalex.org/W2179699524","https://openalex.org/W2798475586"],"related_works":["https://openalex.org/W1998076790","https://openalex.org/W2883882337","https://openalex.org/W4390858028","https://openalex.org/W4396706069","https://openalex.org/W2479870945","https://openalex.org/W1995017657","https://openalex.org/W1974156328","https://openalex.org/W1608225731","https://openalex.org/W3006150517","https://openalex.org/W1501655149"],"abstract_inverted_index":{"Passive":[0,64],"immunotherapy":[1,35,65],"is":[2],"one":[3],"of":[4,15,44,97,122,131,135,160,212,235,259,266,277,291,298],"the":[5,13,21,25,30,41,74,78,90,98,128,144,158,162,185,198,209,213,223,236,245,267,275,283,289],"most":[6,192],"exciting":[7],"and":[8,47,61,190,215,255,269,274],"extensively":[9],"researched":[10],"areas":[11],"in":[12,34,50,94,108,197,288],"field":[14],"Alzheimer's":[16,149],"disease":[17,295],"(AD)":[18],"today,":[19],"harbouring":[20],"potential":[22,75,173],"to":[23,76,81,184,221,229,238,249,252,261],"become":[24],"first":[26],"disease-modifying":[27],"treatment":[28,38],"for":[29,52],"disease.":[31],"The":[32,152,170,264],"interest":[33],"as":[36,72,174,176],"a":[37,86,118,167,294],"stemmed":[39],"from":[40,126],"significant":[42,87],"dangers":[43],"toxic":[45],"side-effects":[46],"major":[48],"obstacles":[49],"selectivity":[51],"currently":[53,232],"pursued":[54],"therapies":[55],"against":[56],"amyloid":[57],"beta":[58],"(A\u03b2)":[59],"proteins":[60],"neurofibrillary":[62],"tangles.":[63],"especially,":[66],"has":[67],"received":[68],"much":[69],"limelight,":[70],"seen":[71],"having":[73],"be":[77,230,250],"safer":[79],"alternative":[80],"active":[82],"immunisation":[83,106,139],"which":[84,95],"encountered":[85],"setback":[88],"with":[89],"notorious":[91],"AN-1972":[92],"trial":[93],"6%":[96],"vaccinated":[99],"patients":[100],"developed":[101],"meningoencephalitis.":[102],"At":[103],"present,":[104],"passive":[105,138,279],"research":[107],"animal":[109],"models":[110],"have":[111,204,216],"exclusively":[112],"focused":[113],"on":[114,125,148,219],"targeting":[115,200],"A\u03b2":[116],"proteins,":[117],"widely":[119],"accepted":[120],"pathology":[121],"AD.":[123,299],"Following":[124],"this,":[127],"preliminary":[129],"results":[130,171,265],"phase":[132,271],"II":[133],"trials":[134,273],"three":[136,153],"distinct":[137],"strategies":[140,155],"were":[141],"demonstrated":[142,172],"at":[143],"2008":[145],"International":[146],"Conference":[147],"Disease":[150],"(ICAD).":[151],"therapeutic":[154],"each":[156],"targeted":[157],"N-terminal":[159,199],"A\u03b2,":[161],"central":[163,246],"epitope":[164],"or":[165],"utilised":[166],"polyclonal":[168],"approach.":[169],"well":[175],"caution.":[177],"Efficacy":[178],"was":[179,188],"undoubtedly":[180],"present":[181],"but":[182],"not":[183],"extent":[186],"that":[187,240],"hoped":[189],"side-effects,":[191],"notably":[193],"vasogenic":[194],"oedema":[195],"occurred":[196],"antibody,":[201],"bapineuzimab.":[202],"Lessons":[203],"been":[205,217],"learnt":[206],"by":[207],"identifying":[208],"possible":[210],"cause":[211,253,262],"problems":[214,284],"taken":[218],"board":[220],"nurture":[222],"proven":[224],"efficacious":[225],"results.":[226],"Key":[227],"points":[228],"addressed":[231],"are":[233,285],"dosage":[234],"agent":[237],"ensure":[239],"high":[241],"enough":[242,257],"concentrations":[243],"enter":[244],"nervous":[247],"system":[248],"available":[251],"effect":[254],"early":[256],"time":[258],"administration":[260],"effect.":[263],"efficacy":[268],"safety":[270],"III":[272],"development":[276],"newer":[278],"immunotherapeutic":[280],"agents":[281],"addressing":[282],"eagerly":[286],"awaited":[287],"hope":[290],"finally":[292],"yielding":[293],"modifying":[296],"therapy":[297]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}